New study checks if Triple-Inhaler trimbow really helps COPD patients Day-to-Day
NCT ID NCT06480890
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how well the Trimbow inhaler works for people with COPD when used in everyday life, not just in a lab. 362 adults with COPD used the inhaler for 12 weeks. Researchers measured changes in a COPD symptom questionnaire to see if patients felt better. The goal was to see if this triple-combination inhaler improves breathing and quality of life outside of strict clinical trial conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Trimbow (beclometasone, formoterol, glycopyrronium) inhaler
- What this could lead to
- If successful, this study could confirm that Trimbow helps COPD patients breathe better and manage their condition more effectively in everyday life.
- What could go wrong
- This is a small, short-term study without a comparison group, so results may not prove the drug works better than other treatments. It also only looks at symptom scores, not long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Site 156101 - The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510120, China
-
Site 156102 - Mianyang Central Hospital
Mianyang, Sichuan, 450003, China
-
Site 156103 - Shaoxing People's Hospital
Shaoxing, Zhejiang, 312000, China
-
Site 156105 - Taizhou Central Hospital
Taizhou, Zhejiang, 318000, China
-
Site 156106 - Huzhou Central Hospital
Huzhou, Zhejiang, 313000, China
-
Site 156108 - Henan Provincial People's Hospital
Zhengzhou, Henan, 450003, China
-
Site 156109 - Shandong Provincial Hospital
Jinan, Shandong, 250021, China
-
Site 156110 Beijing Jingmei Group Genetal Hospital
Beijing, Beijing Municipality, 102300, China
-
Site 156112 - The First Affiliated Hospital of Ningbo University
Ningbo, Zhejiang, 315010, China
-
Site 156113 - The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510260, China
-
Site 156114 - The Second Affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangdong, 524003, China
-
Site 156115 - Jinhua Central Hospital
Jinhua, Zhejiang, 321083, China
-
Site 156117 - The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, 710004, China
-
Site 156119 - Peking University People's Hospital
Beijing, Beijing Municipality, 100033, China
-
Site 156121 - The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang Uygur, 830054, China
-
Site 156122 - Deyang People's Hospital
Deyang, Sichuan, 618000, China
-
Site 156123 - Wenling People's Hospital
Wenling, Zhejiang, 317599, China
-
Site 156124 - Lishui People's Hospital
Lishui, Zhejiang, 323088, China
-
Site 156125 - Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210008, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart breathing machines at home: a new way to predict COPD crises?
- Breathing easy? new X-Ray method may spot COPD decline early
- Could a common heart drug cut COPD hospitalizations?
- Which inhaler breathes better? a Head-to-Head COPD showdown
- Could tiny lung valves revive heart and muscle strength in COPD?
- One lung or two? surgery trial aims to find the best approach for severe COPD